| Latent period |  | Incubation period | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Delta (672) | Â | Omicron (885) | Â | Delta (405) | Â | Omicron (420) | |||||
exp (\( \varvec{\beta }\)) (95%CI) | p value | Â | exp (\( \varvec{\beta }\)) (95%CI) | p value | Â | exp (\( \varvec{\beta }\)) (95%CI) | p value | Â | exp (\( \varvec{\beta }\)) (95%CI) | p value | |
Sex | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Male | 1 (ref) | ·· |  | 1 (ref) | ·· |  | 1 (ref) | ·· |  | 1 (ref) | ·· |
Female | 1.01 (0.91 ~ 1.13) | 0.839 |  | 0.95 (0.87 ~ 1.05) | 0.334 |  | 0.99 (0.88 ~ 1.11) | 0.887 |  | 0.97 (0.88 ~ 1.07) | 0.546 |
Age | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
0 ~ 17 | 1 (ref) | ·· |  | 1 (ref) | ·· |  | 1 (ref) | ·· |  | 1 (ref) | ·· |
18 ~ 49 | 0.81 (0.66 ~ 0.98) | 0.034 |  | 0.82 (0.71 ~ 0.94) | 0.004 |  | 0.69 (0.55 ~ 0.86) | < 0.001 |  | 0.83 (0.72 ~ 0.96) | 0.013 |
50~ | 1.04 (0.87 ~ 1.25) | 0.669 |  | 1.07 (0.92 ~ 1.26) | 0.373 |  | 0.89 (0.71 ~ 1.10) | 0.270 |  | 0.95 (0.80 ~ 1.14) | 0.593 |
Vaccination history | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Unvaccinated | 1 (ref) | ·· |  | 1 (ref) | ·· |  | 1 (ref) | ·· |  | 1 (ref) | ·· |
Partially vaccinated | 0.97 (0.85 ~ 1.11) | 0.676 |  | 1.05 (0.78 ~ 1.41) | 0.757 |  | 0.96 (0.84 ~ 1.11) | 0.606 |  | 0.98 (0.75 ~ 1.27) | 0.856 |
Fully vaccinated | 0.98 (0.85 ~ 1.13) | 0.789 |  | 1.07 (0.88 ~ 1.28) | 0.501 |  | 1.00 (0.86 ~ 1.16) | 0.962 |  | 1.03 (0.86 ~ 1.23) | 0.751 |
Booster | ·· | ·· |  | 0.97 (0.81 ~ 1.17) | 0.780 |  | ·· | ·· |  | 1.02 (0.85 ~ 1.21) | 0.864 |
Clinical severity | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Asymptomatic | 1 (ref) | ·· |  | 1 (ref) | ·· |  | NA | NA |  | NA | NA |
Mild | 1.35 (0.90 ~ 2.04) | 0.148 |  | 1.00 (0.89 ~ 1.13) | 0.969 |  | 1 (ref) | ·· |  | 1 (ref) | ·· |
Moderate/Severe/Critical | 1.23 (0.83 ~ 1.83) | 0.304 |  | 0.99 (0.84 ~ 1.17) | 0.914 |  | 1.02 (0.86 ~ 1.20) | 0.864 |  | 1.07 (0.91 ~ 1.26) | 0.395 |
Number of infectors | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
> 1 | 1 (ref) | ·· |  | 1 (ref) | ·· |  | 1 (ref) | ·· |  | 1 (ref) | ·· |
= 1 | 0.92 (0.81 ~ 1.04) | 0.190 |  | 0.96 (0.87 ~ 1.05) | 0.378 |  | 0.90 (0.79 ~ 1.03) | 0.133 |  | 0.99 (0.90 ~ 1.10) | 0.904 |
Exposure window | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
≤ 3 days | 1 (ref) | ·· |  | 1 (ref) | ·· |  | 1 (ref) | ·· |  | 1 (ref) | ·· |
> 3 days | 1.06 (0.94 ~ 1.19) | 0.359 |  | 1.51 (1.35 ~ 1.70) | < 0.001 |  | 1.05 (0.92 ~ 1.19) | 0.469 |  | 1.48 (1.32 ~ 1.66) | < 0.001 |
Shedding window | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
≤ 3 days | 1 (ref) | ·· |  | 1 (ref) | ·· |  | 1 (ref) | ·· |  | 1 (ref) | ·· |
> 3 days | 0.80 (0.70 ~ 0.90) | < 0.001 |  | 0.85 (0.71 ~ 1.02) | 0.081 |  | 0.96 (0.86 ~ 1.07) | 0.469 |  | 1.21 (1.08 ~ 1.36) | 0.001 |
Omicron sublineages | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
BA.1 | NA | NA |  | 1 (ref) | ·· |  | NA | NA |  | 1 (ref) | ·· |
BA.2 | NA | NA |  | 0.99 (0.88 ~ 1.12) | 0.886 |  | NA | NA |  | 1.03 (0.90 ~ 1.18) | 0.648 |